Previous medications had typically produced 5-8% weight loss
Other possibilities include diverticular disease, inflammatory bowel disease, colorectal polyps or cancer, and medication-related bleeding from concurrent use of anticoagulants, antiplatelet agents, or NSAIDs
Adequate protein intake, regular physical activity, and sufficient sleep help counter this effect
It is important to regularly check in with your healthcare provider while using tirzepatide or semaglutide to monitor for any long-term risks and make adjustments to your treatment as needed
Download our white paper here: Related solutions Discover new approaches to cardiovascular clinical trials to bring game-changing therapies to patients faster
TRIUMPH-4 (obesity with knee osteoarthritis) reported positive results in late last year